摘要 |
<p>A novel pyrimidine nucleoside compound, or its salt, of the general formula: (1) wherein one of X and Y is a cyano while the other is a hydrogen atom; and one of R<sup>1</sup> and R<sup>2</sup> is a hydrogen atom, a carbonyl having an alkyl monosubstituted with amino, or a group of the formula (R<sup>3</sup>)(R<sup>4</sup>)(R<sup>5</sup>)Si- while the other is a silyl of the formula (R<sup>6</sup>)(R<sup>7</sup>)(R<sup>8</sup>)Si-, or alternatively R<sup>1</sup> and R<sup>2</sup> together represent a group of the formula -Si(R<sup>9</sup>)(R<sup>10</sup>)- and may form a six-membered cyclic group, provided that each of R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup> and R<sup>8</sup> is an alkyl, a cycloalkyl, an aryl or an alkyl substituted with one or two aryls, and that R<sup>9</sup> and R<sup>10</sup> are alkyls. The provided novel pyrimidine nucleoside compounds exhibit antitumor efficacy higher than those of conventional pyrimidine nucleoside compounds.</p> |